This week we discuss what a biosimilar is, why they’re causing such controversy and why they’ve taken seven years, since the FDA approved Amgevita, to come to market. We review the evidence behind the safety and efficacy of these drugs, the data from switching from a bio-originator to a...

This week, we have the distinct privilege to interview Dr. Dan Kaster, “The Father of Autio inflammatory Diseases”. His discoveries have taught us a great deal about how the immune system works, both in health and disease. His work has contributed to finding effective treatments for conditions...